ArticleJournal of the Chinese Medical Association : JCMA2025

Real-world outcomes of everolimus-based treatment in a Taiwanese cohort with metastatic HR+/HER2- breast cancer.

Yun-Chieh Kao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.